Hapvida Shares Rise 5.3% After Making Changes to Board
By Jeffrey T. Lewis
SÃO PAULO--Hapvida Participações e Investimentos's shares rose 5.3% after the Brazilian hospital and clinic operator made a series of changes to its board.
The shares reached 3.80 reais (77 U.S. cents) and were down 29% from the end of last year through Friday's close. Brazil's benchmark Ibovespa stocks index was little changed in mid-afternoon trading.
Hapvida said Friday after the close that three members of its board resigned and that three new members were elected to replace them. The changes increase the number of independent members on the company's board to four out of nine seats, Itaú BBA analysts said in a research note
The three new members have extensive experience and the moves reflect the new situation in the company after a takeover of Grupo NotreDame Intermédica last year, the analysts said. Hapvida's controlling shareholders and executive team are taking control of the company and of the integration process, the analysts said.
Write to Jeffrey T. Lewis at jeffrey.lewis@wsj.com
(END) Dow Jones Newswires
May 22, 2023 14:17 ET (18:17 GMT)
Copyright (c) 2023 Dow Jones & Company, Inc.-
Never Mind Market Efficiency: Are the Markets Sensible?
-
Starbucks Stock Could Use a Pick-Me-Up After Big Selloff; Is it a Buy?
-
5 Cheap Stocks to Buy From an Attractive Part of the Market
-
Markets Brief: All Eyes On Inflation
-
5 Things We Learned From the Q1 Earnings Season
-
After Earnings, Is Palantir Stock a Buy, a Sell, or Fairly Valued?
-
What’s Happening In the Markets This Week
-
Can the Fed Declare Victory on Inflation?
-
Going Into Earnings, Is Nvidia Stock a Buy, a Sell, or Fairly Valued?
-
After Earnings, Is Arista Stock a Buy, a Sell, or Fairly Valued?
-
A Cheap Dividend Aristocrat to Buy Before It Bounces Back
-
Alibaba Earnings: More Positive Outlook Despite Mixed Results
-
After Earnings and a 56% Rally In 2024, Is Arm Stock a Buy, a Sell, or Fairly Valued?
-
How Morningstar Rates Stocks
-
After Earnings, Is Disney Stock a Buy, a Sell, or Fairly Valued?
-
Home Depot Earnings: Macro Factors Pinch Demand, but Long-Term Outlook Intact